• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.

PDT may aid patients with minimally classic CNV

January 1, 2002

Study of verteporfin therapy leads to new VIM Trial to determine effectof fluence rate, light dose